Registration Options

Activity Dates: 10/03/2025 - 10/03/2028

Session Time

Date: Friday, 10/03/2025

Time: 3:00 PM (view in the schedule)

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Migraine affects over one billion people globally and is a significant cause of disability, particularly during prime working years. Psychiatric comorbidities such as depression, anxiety, and PTSD are associated with migraines, leading to increased health care resource utilization and chronic migraine. Since 2018, eight novel-mechanism calcitonin gene-related peptide (CGRP) antagonists have been FDA-approved for migraine treatment, highlighting the need for education on their use. Surveys indicate that many individuals with migraine have unmet treatment needs, and psychiatric pharmacists play a crucial role in addressing these through advanced decision-making strategies and patient-specific care. This session aims to help psychiatric pharmacists understand the risks, benefits, and treatment strategies for implementing CGRP antagonists in the treatment of migraines.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Mikiko Y. Takeda, PharmD, MS, BCACP, FAES

View biographical information

Learning Objectives

  1. Identify potential risks and/or benefits of using calcitonin gene-related peptide antagonists for the treatment of migraine based on available data and clinical experience.
  2. Design a treatment regimen for migraine when given a patient case scenario.
  3. Modify migraine treatment regimens to align with individual patient needs, preferences, and treatment goals.

 

Continuing Education Credit and Disclosures

Activity Dates: 10/03/2025 - 10/03/2028
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-25-032-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.